Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | JNJ Johnson & Johnson | ABT Abbott Laboratories |
|---|---|---|
| Price | $269.99 -0.1% | $102.61 +0.4% |
| StockIQ Score | 59C Moderate Risk: Medium | 51C- Moderate Risk: Medium |
| Technical | 59C | 19F |
| Fundamental | 70B | 72B |
| Growth | 62C+ | 45D+ |
| Fair Value | 38F | 38F |
| News | 74B | 100A+ |
| Quality | 50C- | 63C+ |
| Risk | 58C | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Johnson & Johnson (JNJ) scores higher on investor (59 vs 51), technical (59 vs 19) and growth (62 vs 45) than Abbott Laboratories (ABT). ABT leads on fundamental score (72 vs 70). Both have the same valuation score of 38.